TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer
Arkenau, HT ; Tabernero, J ; Shitara, K ; Dvorkin, M ; Mansoor, Was ; Prokharau, A ; Alsina, M ; Ghidini, M ; Faustino, C ; Gorbunova, V ... show 10 more
Arkenau, HT
Tabernero, J
Shitara, K
Dvorkin, M
Mansoor, Was
Prokharau, A
Alsina, M
Ghidini, M
Faustino, C
Gorbunova, V
Citations
Altmetric:
Abstract
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Arkenau HT, Tabernero J, Shitara K, Dvorkin M, Mansoor W, Prokharau A, et al. LBA25 TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer. Annals of Oncology. 2018;29(suppl_8).